These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 16204069)

  • 21. Risk prediction of gastric cancer by analysis of aberrant DNA methylation in non-neoplastic gastric epithelium.
    Tahara T; Arisawa T; Shibata T; Wang FY; Nakamura M; Sakata M; Nagasaka M; Takagi T; Kamiya Y; Fujita H; Nakamura M; Hasegawa S; Iwata M; Takahama K; Watanabe M; Hirata I; Nakano H
    Digestion; 2007; 75(1):54-61. PubMed ID: 17438355
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High frequency of promoter hypermethylation of RASSF1A and p16 and its relationship to aflatoxin B1-DNA adduct levels in human hepatocellular carcinoma.
    Zhang YJ; Ahsan H; Chen Y; Lunn RM; Wang LY; Chen SY; Lee PH; Chen CJ; Santella RM
    Mol Carcinog; 2002 Oct; 35(2):85-92. PubMed ID: 12325038
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Detection of hypermethylated genes in tumor and plasma of cervical cancer patients.
    Yang HJ; Liu VW; Wang Y; Chan KY; Tsang PC; Khoo US; Cheung AN; Ngan HY
    Gynecol Oncol; 2004 May; 93(2):435-40. PubMed ID: 15099958
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Polymorphism in folate- and methionine-metabolizing enzyme and aberrant CpG island hypermethylation in uterine cervical cancer.
    Kang S; Kim JW; Kang GH; Park NH; Song YS; Kang SB; Lee HP
    Gynecol Oncol; 2005 Jan; 96(1):173-80. PubMed ID: 15589597
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic implication of aberrant promoter hypermethylation of CpG islands in adenocarcinoma of the lung.
    Kim YT; Park SJ; Lee SH; Kang HJ; Hahn S; Kang CH; Sung SW; Kim JH
    J Thorac Cardiovasc Surg; 2005 Nov; 130(5):1378. PubMed ID: 16256792
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CpG island methylation of genes accumulates during the adenoma progression step of the multistep pathogenesis of colorectal cancer.
    Kim YH; Petko Z; Dzieciatkowski S; Lin L; Ghiassi M; Stain S; Chapman WC; Washington MK; Willis J; Markowitz SD; Grady WM
    Genes Chromosomes Cancer; 2006 Aug; 45(8):781-9. PubMed ID: 16708352
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Methylation and expression analysis of 15 genes and three normally-methylated genes in 13 Ovarian cancer cell lines.
    Imura M; Yamashita S; Cai LY; Furuta J; Wakabayashi M; Yasugi T; Ushijima T
    Cancer Lett; 2006 Sep; 241(2):213-20. PubMed ID: 16303245
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Germ-line variants in methyl-group metabolism genes and susceptibility to DNA methylation in human breast cancer.
    Li SY; Rong M; Iacopetta B
    Oncol Rep; 2006 Jan; 15(1):221-5. PubMed ID: 16328059
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High-resolution methylation analysis of the BRCA1 promoter in ovarian tumors.
    Wilcox CB; Baysal BE; Gallion HH; Strange MA; DeLoia JA
    Cancer Genet Cytogenet; 2005 Jun; 159(2):114-22. PubMed ID: 15899382
    [TBL] [Abstract][Full Text] [Related]  

  • 30. DNMT1 is required to maintain CpG methylation and aberrant gene silencing in human cancer cells.
    Robert MF; Morin S; Beaulieu N; Gauthier F; Chute IC; Barsalou A; MacLeod AR
    Nat Genet; 2003 Jan; 33(1):61-5. PubMed ID: 12496760
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Methylation profiles of sporadic ovarian tumors and nonmalignant ovaries from high-risk women.
    Rathi A; Virmani AK; Schorge JO; Elias KJ; Maruyama R; Minna JD; Mok SC; Girard L; Fishman DA; Gazdar AF
    Clin Cancer Res; 2002 Nov; 8(11):3324-31. PubMed ID: 12429618
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CpG island methylator phenotype (CIMP) in cancer: causes and implications.
    Teodoridis JM; Hardie C; Brown R
    Cancer Lett; 2008 Sep; 268(2):177-86. PubMed ID: 18471961
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CpG island methylator phenotypes in aging and cancer.
    Toyota M; Issa JP
    Semin Cancer Biol; 1999 Oct; 9(5):349-57. PubMed ID: 10547343
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Polymorphisms in methyl-group metabolism genes and risk of sporadic colorectal cancer with relation to the CpG island methylator phenotype.
    Karpinski P; Myszka A; Ramsey D; Misiak B; Gil J; Laczmanska I; Grzebieniak Z; Sebzda T; Smigiel R; Stembalska A; Sasiadek MM
    Cancer Epidemiol; 2010 Jun; 34(3):338-44. PubMed ID: 20381446
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Germ-line variants in methyl-group metabolism genes and susceptibility to DNA methylation in normal tissues and human primary tumors.
    Paz MF; Avila S; Fraga MF; Pollan M; Capella G; Peinado MA; Sanchez-Cespedes M; Herman JG; Esteller M
    Cancer Res; 2002 Aug; 62(15):4519-24. PubMed ID: 12154064
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aberrant gene promoter methylation in plasma cell dyscrasias.
    Martin P; Garcia-Cosio M; Santon A; Bellas C
    Exp Mol Pathol; 2008 Jun; 84(3):256-61. PubMed ID: 18410922
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Global methylation profiling in serous ovarian cancer is indicative for distinct aberrant DNA methylation signatures associated with tumor aggressiveness and disease progression.
    Keita M; Wang ZQ; Pelletier JF; Bachvarova M; Plante M; Gregoire J; Renaud MC; Mes-Masson AM; Paquet ÉR; Bachvarov D
    Gynecol Oncol; 2013 Feb; 128(2):356-63. PubMed ID: 23219462
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Primary ovarian carcinomas display multiple methylator phenotypes involving known tumor suppressor genes.
    Strathdee G; Appleton K; Illand M; Millan DW; Sargent J; Paul J; Brown R
    Am J Pathol; 2001 Mar; 158(3):1121-7. PubMed ID: 11238060
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Aberrant promoter methylation of multiple genes in malignant ovarian tumors and in ovarian tumors with low malignant potential.
    Wiley A; Katsaros D; Chen H; Rigault de la Longrais IA; Beeghly A; Puopolo M; Singal R; Zhang Y; Amoako A; Zelterman D; Yu H
    Cancer; 2006 Jul; 107(2):299-308. PubMed ID: 16773633
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differential DNA methylation profiles in gynecological cancers and correlation with clinico-pathological data.
    Yang HJ; Liu VW; Wang Y; Tsang PC; Ngan HY
    BMC Cancer; 2006 Aug; 6():212. PubMed ID: 16928264
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.